Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Macular pucker surgery with and without delamination of the internal limiting membrane-a prospective randomized study].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2019

Same author

[Does the micropulse laser have an effect on chronic CSC?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018

Same author

[Prognosis and treatment of macular bleeding in neovascular age-related macular degeneration].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017

Same author

[Intravitreal dexamethasone implant for treatment of persistent postoperative macular edema after vitrectomy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2016

Same author

[Importance of the Watzke-Allen test in diagnostics and staging of macular holes].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2015

Same author

[Progressive scotoma with perception of photopsia].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2015

Same journal

["DOG 2020 online" - for the first time in the von Graefe year].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2024

Same journal

[Are organ and co-cultures an alternative to animal models in ophthalmology?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

Same journal

[Pediatric corneal opacities : Even small improvements provide lifelong help].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

Same journal

[Myxoma of the conjunctiva].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

Same journal

[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

Same journal

[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

[siRNA in macular degeneration].

J Callizo¹, H T Agostini

¹Universitäts-Augenklinik, Universitäts-Augenklinik Freiburg, Killianstrasse 5, Freiburg, Deutschland. Josep.Callizo@uniklinik-freiburg.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft

|July 24, 2010

Summary

This summary is machine-generated.

Current ocular angiogenesis treatments like aptamers offer temporary inhibition. Small interfering RNA (siRNA) therapies are emerging as a promising alternative for sustained gene silencing and improved treatment outcomes.

More Related Videos

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Related Experiment Videos

Last Updated: Jun 10, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

Area of Science:

Ophthalmology
Molecular Biology
Pharmacology

Context:

Ocular angiogenesis is a key factor in various eye diseases.
Current therapies include aptamers, antibodies, and antibody fragments.
These approved treatments provide temporary inhibition of vascular growth and permeability.

Purpose:

To review small interfering RNA (siRNA) as a therapeutic strategy for ocular angiogenesis.
To discuss mechanisms, molecule design, and clinical applications of siRNA.
To present initial clinical experiences with siRNA in ophthalmology.

Summary:

Aptamers, recombinant antibodies, and antibody fragments are approved for ocular angiogenesis by blocking signaling molecules.
These therapies offer temporary inhibition of neovascularization and vascular permeability.
Small interfering RNA (siRNA) is being evaluated for post-transcriptional gene silencing via mRNA degradation, offering a potential alternative.

Impact:

siRNA represents a novel therapeutic approach for sustained inhibition of ocular angiogenesis.
Understanding siRNA mechanisms and design is crucial for developing effective treatments.
Clinical data on siRNA in ophthalmology will guide future therapeutic strategies and patient care.